HTSUY Projected Dividend Yield
ADR/Hisamitsu Pharmaceutical Co Inc ( OTCBB : HTSUY )Hisamitsu Pharmaceutical is a pharmaceutical company. Along with its affiliates, Co. is mainly engaged in the pharmaceutical business in Japan and overseas. Co. is engaged in the manufacture and sale of pharmaceuticals and related products, including OTC products and ethical products. Co.'s principal product brands are called "SALONPASs®," "SALONSIP®," "ByeBye-FEVER®," "Lifecella®," "MOHRUS®" and "KEPLAT®." In addition, Co. is involved in the provision of urban cable television broadcasting and Internet connection services; the sale and rearing of experimental animals; and the non-life insurance agency and advertising agency businesses. 16 YEAR PERFORMANCE RESULTS |
HTSUY Dividend History Detail HTSUY Dividend News HTSUY Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
2024 |
N/A |
N/A |
Feb 29, 2024 |
Jun 10, 2024 |
0.0677 |
2024 Total: |
0.0677 |
||||
2023 |
N/A |
N/A |
Aug 31, 2023 |
Nov 21, 2023 |
0.0705 |
2023 |
N/A |
N/A |
Feb 28, 2023 |
Jul 12, 2023 |
0.0752 |
2023 Total: |
0.1457 |
||||
2022 |
N/A |
N/A |
Aug 31, 2022 |
Nov 25, 2022 |
0.0720 |
2022 |
N/A |
N/A |
Feb 25, 2022 |
Jun 13, 2022 |
0.0825 |
2022 Total: |
0.1546 |
||||
2021 |
N/A |
N/A |
Aug 30, 2021 |
Nov 29, 2021 |
0.0921 |
2021 |
N/A |
N/A |
Feb 26, 2021 |
Jun 14, 2021 |
0.0947 |
2021 Total: |
0.1868 |
||||
2020 |
N/A |
N/A |
Aug 28, 2020 |
Nov 20, 2020 |
0.1006 |
2020 |
N/A |
N/A |
Feb 28, 2020 |
Jun 08, 2020 |
0.0933 |
2020 Total: |
0.1938 |
||||
2019 |
N/A |
N/A |
Aug 30, 2019 |
Nov 22, 2019 |
0.0950 |
2019 |
N/A |
N/A |
Feb 27, 2019 |
Jun 10, 2019 |
0.0941 |
2019 Total: |
0.1891 |